Skip to main content

Table 4 Lipid and apolipoprotein mean concentrations (± SD) in controls and CAD patients.

From: Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

  Control (N = 50) CAD (N = 50) P
TC (mmol/L) 4.01 ± 0.46 4.62 ± 0.9 <0.001
TG (mmol/L) 0.78 ± 1.78 1.76 ± 0.77 <0.001
HDL-C (mmol/L) 1.07 ± 0.12 0.92 ± 0.26 <0.001
LDL-C (mmol/L) 2.57 ± 0.44 2.95 ± 0.86 <0.01
Apo AI (g/L) 1.33 ± 0.17 1.04 ± 0.13 <0.001
Apo B (g/L) 0.76 ± 0.18 1.00 ± 0.35 <0.001
Apo E (mg/L) 50.24 ± 7.63 43.24 ± 11.33 <0.001
Apo B/ApoAI 0.59 ± 0.16 0.96 ± 0.31 <0.001
Homocysteine (μmol/L) 12.93 ± 1.12 16.6 ± 4.58 <0.001
  1. P: Student t-test probability for comparisons among Control and CAD groups.